DA Carson

1.6k total citations
16 papers, 1.3k citations indexed

About

DA Carson is a scholar working on Genetics, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, DA Carson has authored 16 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 4 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in DA Carson's work include Chronic Lymphocytic Leukemia Research (10 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Viral-associated cancers and disorders (3 papers). DA Carson is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Viral-associated cancers and disorders (3 papers). DA Carson collaborates with scholars based in United States and Switzerland. DA Carson's co-authors include TJ Kipps, CJ Carrera, LD Piro, Ernest Beutler, Alice L. Yu, Raymond Taetle, Alan Saven, T J Kipps, Hajime Kawasaki and GJ Silverman and has published in prestigious journals such as Blood and Arthritis Research.

In The Last Decade

DA Carson

16 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
DA Carson United States 13 881 558 426 338 288 16 1.3k
LD Piro United States 10 578 0.7× 391 0.7× 292 0.7× 127 0.4× 243 0.8× 12 821
C Hirsch-Ginsberg United States 14 681 0.8× 455 0.8× 455 1.1× 151 0.4× 295 1.0× 19 1.2k
C. P. Worman United Kingdom 19 611 0.7× 335 0.6× 830 1.9× 216 0.6× 175 0.6× 61 1.2k
HM Kantarjian United States 19 822 0.9× 336 0.6× 237 0.6× 358 1.1× 455 1.6× 30 1.6k
Susan O’Brien United States 21 533 0.6× 231 0.4× 205 0.5× 489 1.4× 236 0.8× 56 1.3k
Alessandra Pucciarini Italy 14 413 0.5× 691 1.2× 345 0.8× 475 1.4× 413 1.4× 19 1.4k
JC Cawley United Kingdom 19 493 0.6× 241 0.4× 487 1.1× 234 0.7× 188 0.7× 46 1.0k
Piers Patten United Kingdom 16 867 1.0× 602 1.1× 492 1.2× 231 0.7× 315 1.1× 72 1.2k
C J Carrera United States 7 404 0.5× 175 0.3× 151 0.4× 307 0.9× 260 0.9× 8 823
CE Grossi Italy 16 289 0.3× 225 0.4× 418 1.0× 183 0.5× 105 0.4× 25 755

Countries citing papers authored by DA Carson

Since Specialization
Citations

This map shows the geographic impact of DA Carson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DA Carson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DA Carson more than expected).

Fields of papers citing papers by DA Carson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DA Carson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DA Carson. The network helps show where DA Carson may publish in the future.

Co-authorship network of co-authors of DA Carson

This figure shows the co-authorship network connecting the top 25 collaborators of DA Carson. A scholar is included among the top collaborators of DA Carson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DA Carson. DA Carson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Rethage, Janine, Reinhart Seibl, BA Michel, et al.. (2002). Bacterial peptidoglycan stimulates integrin expression and MMP production of synovial fibroblasts. Arthritis Research. 4(Suppl 1). 31–31. 1 indexed citations
2.
Kipps, TJ & DA Carson. (1993). Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases. Blood. 81(10). 2475–2487. 142 indexed citations
3.
4.
Kipps, TJ & DA Carson. (1993). Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases. Blood. 81(10). 2475–2487. 121 indexed citations
5.
6.
Saven, Alan, CJ Carrera, DA Carson, Ernest Beutler, & LD Piro. (1992). 2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T- cell lymphoma. Blood. 80(3). 587–592. 86 indexed citations
7.
Saven, Alan, CJ Carrera, DA Carson, Ernest Beutler, & LD Piro. (1992). 2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T- cell lymphoma. Blood. 80(3). 587–592. 66 indexed citations
10.
Piro, LD, CJ Carrera, Ernest Beutler, & DA Carson. (1988). 2-Chlorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemia. Blood. 72(3). 1069–1073. 207 indexed citations
11.
Piro, LD, CJ Carrera, Ernest Beutler, & DA Carson. (1988). 2-Chlorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemia. Blood. 72(3). 1069–1073. 150 indexed citations
13.
Carson, DA, et al.. (1983). Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes. Blood. 62(4). 737–743. 21 indexed citations
14.
Carson, DA, et al.. (1983). Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes. Blood. 62(4). 737–743. 230 indexed citations
15.
Yu, Alice L., et al.. (1982). Deficiency of methylthioadenosine phosphorylase in human leukemic cells in vivo. Blood. 60(6). 1387–1391. 23 indexed citations
16.
Yu, Alice L., et al.. (1982). Deficiency of methylthioadenosine phosphorylase in human leukemic cells in vivo. Blood. 60(6). 1387–1391. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026